1. Home
  2. ASMB vs VABK Comparison

ASMB vs VABK Comparison

Compare ASMB & VABK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ASMB
  • VABK
  • Stock Information
  • Founded
  • ASMB 2005
  • VABK 1998
  • Country
  • ASMB United States
  • VABK United States
  • Employees
  • ASMB N/A
  • VABK N/A
  • Industry
  • ASMB Biotechnology: Pharmaceutical Preparations
  • VABK Major Banks
  • Sector
  • ASMB Health Care
  • VABK Finance
  • Exchange
  • ASMB Nasdaq
  • VABK Nasdaq
  • Market Cap
  • ASMB 198.6M
  • VABK 201.8M
  • IPO Year
  • ASMB 2010
  • VABK N/A
  • Fundamental
  • Price
  • ASMB $21.85
  • VABK $41.05
  • Analyst Decision
  • ASMB Strong Buy
  • VABK
  • Analyst Count
  • ASMB 4
  • VABK 0
  • Target Price
  • ASMB $41.33
  • VABK N/A
  • AVG Volume (30 Days)
  • ASMB 148.4K
  • VABK 44.0K
  • Earning Date
  • ASMB 11-06-2025
  • VABK 10-16-2025
  • Dividend Yield
  • ASMB N/A
  • VABK 3.51%
  • EPS Growth
  • ASMB N/A
  • VABK 14.13
  • EPS
  • ASMB N/A
  • VABK 3.31
  • Revenue
  • ASMB $33,247,000.00
  • VABK $56,012,000.00
  • Revenue This Year
  • ASMB $12.44
  • VABK N/A
  • Revenue Next Year
  • ASMB N/A
  • VABK N/A
  • P/E Ratio
  • ASMB N/A
  • VABK $12.40
  • Revenue Growth
  • ASMB 54.77
  • VABK 7.97
  • 52 Week Low
  • ASMB $7.75
  • VABK $33.66
  • 52 Week High
  • ASMB $27.17
  • VABK $44.57
  • Technical
  • Relative Strength Index (RSI)
  • ASMB 40.57
  • VABK 56.13
  • Support Level
  • ASMB $22.36
  • VABK $40.07
  • Resistance Level
  • ASMB $23.61
  • VABK $41.98
  • Average True Range (ATR)
  • ASMB 1.30
  • VABK 2.01
  • MACD
  • ASMB -0.60
  • VABK -0.07
  • Stochastic Oscillator
  • ASMB 3.37
  • VABK 44.65

About ASMB Assembly Biosciences Inc.

Assembly Biosciences Inc is a clinical-stage biotechnology company. It is advancing two platform programs, a novel class of oral therapeutics for the treatment of hepatitis B virus (HBV) infection and novel class of oral synthetic live biotherapeutics, which are designed to restore health to a dysbiotic microbiome. The company's HBV-cure program is aimed at increasing the current low cure rate for patients with HBV and is pursuing multiple drug candidates that inhibit multiple steps of the HBV lifecycle. Assembly has discovered several novel core protein Allosteric Modulators, which are small molecules that directly target and allosterically modulate the HBV core protein. The majority of the revenue is generated from the HBV cure program.

About VABK Virginia National Bankshares Corporation

Virginia National Bankshares Corp is a bank holding company which is engaged in the commercial and retail banking business. The bank offers a range of banking and related financial services, including checking accounts, negotiable order of withdrawal accounts, money market deposit accounts, certificates of deposit, individual retirement accounts and other depository services. Its segments include the Bank, VNB Trust and Estate Services, Sturman Wealth Advisors, and Masonry Capital. The Bank's commercial banking activities involve making loans, taking deposits and offering related services to individuals, businesses, and charitable organizations.

Share on Social Networks: